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RESEARCH ARTICLE

Endoglin potentiates nitric oxide synthesis to enhance definitive
hematopoiesis

ABSTRACT
During embryonic development, hematopoietic cells develop by a
process of endothelial-to hematopoietic transition of a specialized
population of endothelial cells. These hemogenic endothelium (HE)
cells in turn develop from a primitive population of FLK1+ mesodermal
cells. Endoglin (ENG) is an accessory TGF-β receptor that is enriched
on the surface of endothelial and hematopoietic stem cells and is also
required for the normal development of hemogenic precursors.
However, the functional role of ENG during the transition of FLK1+
mesoderm to hematopoietic cells is ill defined. To address this we used
a murine embryonic stem cell model that has been shown to mirror the
temporal emergence of these cells in the embryo. We noted that FLK1+
mesodermal cells expressing ENG generated fewer blast colonyforming cells but had increased hemogenic potential when compared
with ENG non-expressing cells. TIE2+/CD117+ HE cells expressing
ENG also showed increased hemogenic potential compared with
non-expressing cells. To evaluate whether high ENG expression
accelerates hematopoiesis, we generated an inducible ENG
expressing ES cell line and forced expression in FLK1+ mesodermal
or TIE2+/CD117+ HE cells. High ENG expression at both stages
accelerated the emergence of CD45+ definitive hematopoietic cells.
High ENG expression was associated with increased pSMAD2/eNOS
expression and NO synthesis in hemogenic precursors. Inhibition of
eNOS blunted the ENG induced increase in definitive hematopoiesis.
Taken together, these data show that ENG potentiates the emergence
of definitive hematopoietic cells by modulating TGF-β/pSMAD2
signalling and increasing eNOS/NO synthesis.
KEY WORDS: Endoglin, Nitric oxide, FLK1, SMAD2,
Hemogenic endothelium, Hematopoiesis

INTRODUCTION

Endoglin (ENG), also known as CD105, is a 190 kDa homodimeric
transmembrane glycoprotein composed of disulfide-linked subunits
(Gougos and Letarte, 1988). It was first identified on the surface of
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pre-B acute lymphoblastic cells (Zhang et al., 1996), and was later
found abundantly expressed on the surface of vascular endothelial
cells (Cheifetz et al., 1992). ENG functions as an auxiliary receptor
that modulates TGF-β signaling and promotes endothelial cell
proliferation (Barbara et al., 1999). During development, ENG is
first detected at the onset of gastrulation in the extra-embryonic
ectoderm and future amniotic fold at embryonic day (E) 6.5. At
E7–7.5, expression extends to the amnion and allantois and is also
observed in hematopoietic and endothelial cells of yolk sac blood
islands (Ema et al., 2006). By E9.5, ENG is expressed throughout
the developing vasculature and mesenchyme, but is absent from
epithelial cells (Jonker and Arthur, 2002). In addition to its
ubiquitous expression on the surface of proliferating endothelial
cells, ENG is also expressed on endothelial cells and hematopoietic
clusters within the dorsal aorta (DA), which contain emerging
hematopoietic stem cells (HSCs) in the developing embryo
(Cheifetz et al., 1992; Perlingeiro, 2007), and on the surface of
adult bone marrow long-term HSCs (Chen et al., 2002).
The mesoderm that contributes to blood and endothelial cells of
the yolk sac blood islands represents a rare population that migrates
from the posterior primitive streak. Whether the earliest blood and
endothelial cells originate from a shared mesodermal precursor, i.e.
a hemangioblast, or from distinct mesodermal precursors is a moot
point. Whereas in vitro differentiation of embryonic cell populations
and in vivo labelling in zebrafish support the existence of a shared
progenitor (Huber et al., 2004; Vogeli et al., 2006), in vivo labelling
and cell tracing in mice support largely independent origins
(Padrón-Barthe et al., 2014). However, labelling rapidly dividing
heterogeneous cell populations in E5.5–7.5 mouse embryos runs the
risk of reporter systems marking a mix of epiblast, mesodermal,
blood and endothelial progenitors and a method to uniquely label
epiblast cells and trace their progeny in vivo remains elusive.
Nevertheless, a clonal assay that permitted isolation of murine blast
colony–forming cells (BL-CFCs) has been used extensively to
define the presence of and quantify hemangioblasts in vitro and
in vivo (Choi et al., 1998; Huber et al., 2004; Kennedy et al., 1997).
In the presence of VEGF, BL-CFCs form blast colonies which upon
re-plating give rise to primitive and definitive blood progenitors and
endothelial cells (Choi et al., 1998; Kennedy et al., 1997). Blast
colonies express a number of genes common to both hematopoietic
and endothelial lineages, including Scl, CD34, and Flk1 (Kennedy
et al., 1997).
The close spatio-temporal association between ENG expression
and the emergence of hemato-endothelial tissues during development
(Ema et al., 2006; Roques et al., 2012) led to investigations into a
possible functional role for Eng in the embryonic emergence of
blood and endothelium (Borges et al., 2012; Perlingeiro, 2007; Zhang
et al., 2011). These investigations showed that ENG null embryonic
stem (ES) cells had a decreased ability in generating BL-CFC,
and demonstrated reduced primitive erythroid and angiogenic
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differentiation potential (Perlingeiro, 2007; Choi et al., 1998).
Myelopoiesis and definitive erythropoiesis were also severely
impaired in the absence of ENG but lymphopoiesis was only mildly
reduced (Cho et al., 2001). The absence of ENG however did not
appear to perturb expression of early mesodermal markers such as
Brachyury and Flk1 (Perlingeiro, 2007; Cho et al., 2001). Taken
together, these data suggested that ENG plays a role during
commitment of mesodermal precursors to the hematopoietic fate.
However, the precise nature of this role and how ENG promotes
hematopoiesis during early embryonic development are unknown.
In this study, we have taken advantage of the embryoid body (EB)
and liquid culture differentiation systems using ES cells (Fehling
et al., 2003; Lancrin et al., 2009) to functionally evaluate the
hemogenic potential of ENG expressing and non-expressing cell
fractions at different stages of embryonic blood development. We
show that ENG expression in FLK1+ cells mark a population of cells
with early hemogenic and hematopoietic potential. We also show
using an ES cell line engineered to overexpress ENG under
Doxycycline (Dox) control that ENG drives the acceleration of
hemogenic commitment of FLK1+ cells and definitive hematopoiesis
and that it does so by increasing nitric oxide (NO) levels via pSMAD2
signaling and increased eNOS expression.
RESULTS
ENG expressing cells are abundant prior to FLK1 expression
but do not contribute to hematopoiesis.

ENG expression has been reported to both be associated with and also
required for normal hemangioblast development (Perlingeiro, 2007;
Borges et al., 2013). However, the role of ENG during different stages
of hematopoietic commitment is unclear. To evaluate ENG expression
during ES/EB differentiation, we used the Bry-GFP ES cell line,
which has previously been used to characterise the developmental
transition of mesodermal precursors (GFP+/FLK1−) to hemangioblasts
(GFP+/FLK1+) to committed progenitors (GFP−/FLK1+) (Fehling
et al., 2003). ENG is expressed in ∼90% of undifferentiated ES cells
but the proportion of ENG expressing cells fall during ES/EB
differentiation and plateau at ∼days 3–4 (supplementary material
Fig. S1). However, as the frequency of FLK1+ cells increase at
day 5, ENG co-expression also increased (supplementary material
Fig. S1). As expected, Bry-GFP+ cells harvested from day 2 EBs
progressively upregulated FLK1, whereas Bry-GFP− cells, whether
they co-expressed ENG or not, failed to do so (supplementary
material Fig. S2A). This data shows that early ENG expression
is not a determinant of later acquisition of BRY or FLK1
expression (supplementary material Fig. S2A). Furthermore, ENG
expression does not appear to affect the inability of FLK1− cells to
generate CD41+ hematopoietic cells (supplementary material
Fig. S2B).
ENG expression on FLK1+ cells is accompanied by reduced
BL-CFC potential and early commitment towards the
hematopoietic lineage

At day 3 of EB differentiation, Bry-GFP+/FLK1+ mesodermal cells
express threefold more Eng than their FLK1− counterparts
(Fig. 1Ai,ii). Furthermore, flow cytometry data show that ENG
expression within the FLK1+ population is not uniform, where
∼50% of the FLK1+ cells do not express ENG (Fig. 1Bi). BL-CFC
assays performed with cells sorted from each quadrant in Fig. 1Bi
showed that ENG expression on FLK1+ cells in day 3 EBs marked a
population with reduced BL-CFC potential compared with FLK1+
cells that lacked ENG expression (Fig. 1Bii). This observation
was also apparent in cell fractions sorted from day 2.5 EBs
820
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(supplementary material Fig. S3) and was consistent across three
different murine ES cell lines (data not shown).
FLK1+ cells have been shown to lose Bry-GFP expression and
acquire C-KIT (CD117) as they commit to a hemogenic fate (Pearson
et al., 2010). ENG expression preceded CD117 expression and was
enhanced in day 3 Bry-GFP−/FLK1+ cells (Fig. 2A). FLK1+/ENG+
cells were also enriched with hemato-endothelial gene expression
(supplementary material Fig. S4) when compared with FLK1+/ENG−
cells. To investigate whether the reduced BL-CFC potential of
FLK1+/ENG+ cells was indicative of a cell population that had
advanced towards a hemogenic fate, FLK1+/ENG− and FLK1+/ENG+
cells were sorted and cultured in liquid BL-CFC media for four days to
characterise the dynamics of TIE2, CD117 and CD41 acquisition
(Fig. 2Bi,ii). This culture system has previously been used to show
that a subset of TIE2hi/CD117+/CD41− (HEI) cells represent a
population of hemogenic endothelial (HE) cells, that progressively
generate a TIE2+/CD117+/CD41+ (HEII) population followed by
CD41+/CD45− primitive and CD41+/CD45+ definitive hematopoietic
cells (Lancrin et al., 2009). The developmental transition from HEI
to HEII and Tie2−/CD41+ hematopoietic cells was accelerated in
FLK1+/ENG+ cells (35.8% and 50.4% at day 2) when compared with
FLK1+/ENG− cells (24.6% and ∼30%) (Fig. 2Bi,ii). There was also
an increase in total hematopoietic cell number as evident in phasecontrast photographs of the liquid cultures with significantly more
hematopoietic cell formation in FLK1+/ENG+ than in FLK1+/ENG−
cultures at a comparable stage (Fig. 2C). There was an accompanying
increase in the frequency of CD45+ cells at each stage in FLK1+/ENG+
liquid cultures compared with FLK1+/ENG− cultures (Fig. 2D).
To evaluate this in more detail, cells were collected from day 2
liquid blast cultures and seeded into hematopoietic CFU assays.
Significantly more primitive and definitive colonies were generated
from the FLK1+/ENG+ fraction compared with the FLK1+/ENG−
fraction (Fig. 2E). There was no skewing of differentiation towards
any particular lineage (supplementary material Fig. S5). No
hematopoietic colonies were detected in the FLK1− fractions
regardless of ENG expression. It is salient to note however that
FLK1+/ENG− cells do not remain ENG− for long and rapidly
express ENG and at 24 hours there is little difference in ENG
expression between pre-culture FLK1+/ENG− and FLK1+/ENG+
cells in liquid culture (supplementary material Fig. S6). Taken
together with the decrease in BL-CFC potential in FLK1+/ENG+
cells compared with FLK1+/ENG− cells, these data suggest that
surface expression of ENG in FLK1+ cells marks a population of
cells that are more advanced in their development towards a
hematopoietic fate.
Induced ENG expression in FLK1+ mesoderm increases the
frequency of hemogenic endothelial cells and enhances
definitive hematopoiesis

To establish whether ENG expression merely accompanies or
drives the acceleration of hematopoietic commitment of FLK1+
cells, we generated an inducible ENG ES cell line (iEng:GFP)
using parental LoxP-Cre Ainv18 ES cells (Kyba et al., 2002) in
which ENG is linked to GFP via a 2A peptide to facilitate
monitoring (supplementary material Fig. S7). The addition of Dox
at day 0 of ES cell differentiation resulted in the induction of GFP
and sustained surface expression of ENG (supplementary material
Fig. S8Ai,ii). In addition to the proportion of cells expressing
ENG, the abundance of Eng transcripts in Flk1+ cells was also
increased (supplementary material Fig. S8Aiii). As previously
reported, we also observed that Bry expression levels and the
proportion of FLK1 expressing cells were largely unaltered with
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ENG overexpression (Baik et al., 2012) (supplementary material
Fig. S8B). When DOX was added at day 0 to differentiating iEng
ES cells and BL-CFC assays were performed at days 2 and 3,
we saw less BL-CFCs in DOX treated cells compared with
untreated cells (supplementary material Fig. S9). As ENG is
expressed in undifferentiated ES cells and expression falls during
ES differentiation (supplementary material Fig. S1) forced
expression of ENG prior to the emergence of FLK1+ mesoderm
probably skews differentiation towards cell fates other than those
derived from progenitors that give rise to blast colonies.
To investigate the effects of ENG induction in FLK1+ mesoderm,
FLK1+ cells were sorted from day 3 iEng:GFP EBs and cultured in
the presence or absence of Dox in four day liquid cultures (Fig. 3A).
High ENG expression in FLK1+ cells resulted in comparatively
lower frequencies of TIE2+/CD117+ cells and CD41+ cells
(Fig. 3Ai,ii) but increased frequencies of CD45+ cells from day
two onwards (Fig. 3Aiii). Cells collected at day 4 were also seeded
into hematopoietic CFU assays, and showed a significant increase in
the number of definitive hematopoietic colonies following Eng
induction (Fig. 3B). As with endogenous ENG+ versus ENG−
fractions in Fig. 2E and supplementary material Fig S5, there was no
skewing of haematopoiesis towards any particular lineage
(supplementary material Fig. S10). To investigate the relationship

between the decrease in frequencies of TIE2+/CD117+ and CD41+
cells and the increase in CD45+ cell frequencies and definitive
hematopoietic colonies, we quantified the frequency of functional
HE progenitors following Dox treatment. To this end, a limiting
dilution assay (LDA) was performed with sorted FLK1+ cells in the
presence or absence of Dox. After four days, wells containing cells
with hematopoietic morphology were counted. Following ENG
induction in FLK1+ cells the frequency of functional HE cells
increased from 1:341 (untreated) to 1:101 (treated) (Fig. 3C). These
data show that high ENG expression in FLK1+ cells yields higher
numbers of hemogenic progenitors within a diminished pool
of TIE2+/CD117+ cells. Although ENG expression in FLK1+
mesoderm potentiates hematopoiesis, it is not a pre-requisite for HE
commitment and haematopoiesis. FLK1+ mesodermal cells from
day 3 EBs from ENG−/− ES are still able to generate HE and blood
cells in liquid cultures but their numbers, as shown by LDA and
colony counts are severely compromised (supplementary material
Fig. S11).
Induced ENG expression in hemogenic endothelial
progenitors enhances definitive hematopoiesis

To determine if ENG can similarly impact on the kinetics of
blood emergence if overexpressed at later time points, we sorted
821
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Fig. 1. ENG expression on FLK1+ mesodermal cells is associated with reduced BL-CFC potential. (A) (i) A representative graph showing BryGFP and
FLK1 expression by flow cytometry in day 3 EBs. (ii) Eng mRNA expression in sorted BRY+/FLK1− and BRY+/FLK1+ fractions from day 3 EBs. (B) (i) A
representative flow cytometry graph showing surface expression of ENG and FLK1 in day 3 EBs. (ii) Bar chart showing the number of blast colonies generated
from cell fractions sorted from each quadrant in Bi. The error bars represent SEM values across three independent biological replicates each performed in
triplicate. The P values were calculated using a student’s t-test. *=P<0.05; **=P<0.01.
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Fig. 2. ENG expression on FLK1+
mesodermal cells is associated with
early commitment to a hematopoietic
fate. (A) Flow cytometry graphs showing
surface expression of ENG and CD117 in
day 3 BRY+/FLK1−, BRY+/FLK1+ and
BRY−/FLK1+ cell populations. (B) (i)
Representative flow cytometry graphs
showing the expression of CD41 and
TIE2 in FLK1+/ENG+ and FLK+/ENG−
sorted cell fractions during
a four day liquid blast culture assay.
(ii) Corresponding flow cytometry graphs
showing the expression of CD117 and
TIE2 in cell populations in Bi. (C) Phasecontrast photographs of FLK1−/ENG+,
FLK1+/ENG− and FLK1+/ENG+ cells at
day 3 of blast culture. (D) Histogram
showing the percentage of cells
expressing CD45 in cell populations in
Bi. The P values represent the statistical
significance of CD45 expressing cells
between two different cell populations at
the same time point. (E) Bar chart
showing the number of hematopoietic
colonies derived from the FLK1+/ENG+
and FLK+/ENG− cell fractions collected
at day 2 of liquid blast cultures. Each
experiment was performed in triplicate.
The error bars represent the SEM across
three independent experiments. The P
values were calculated using student’s
t-tests from three independent biological
replicates. *P<0.05.
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Fig. 3. See the next page for legend.
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Fig. 3. Induction of high ENG expression in FLK1+ cells in day 3 EBs
enhances their hemogenic potential. iEng:GFP ES cells were differentiated
into day 3 EBs and FLK1 positive cells were sorted and cultured (with or
without Dox) for four days in media supporting blast colony differentiation.
(A) (i) Representative flow cytometry graphs showing CD41 and TIE2 surface
expression during four days of liquid blast cultures of FLK1+ cells with Dox (red)
or without Dox (black). (ii) Representative flow cytometry graphs showing
CD117 and TIE2 surface expression from the same cell populations in Ai.
(iii) Histograms showing the percentage of cells expressing CD45 during
4 days of liquid blast culture. The error bars represent SEM values calculated
from three independent biological replicates. (B) Bar chart showing the number
of hematopoietic colonies in cells isolated from day 2 of culture. (C) FLK1+ cells
sorted from day 3 iEng:GFP EBs were seeded on to a 96 well plate in a limiting
dilution assay (LDA) to quantify the effect of Dox induction on the frequency of
HE. The histograms represent the data obtained from the LDA which shows
that the frequency of HE increases from 1:341 (black) to 1:101 (red) following
induction of ENG. The P values were calculated using t-tests from three
independent biological replicates. *P<0.05.

TIE2+/CD117+ cells from day 2 liquid blast cultures and re-plated
them in the presence or absence of Dox (Fig. 4A). At 48 hours postinduction, the GFP+ fraction was analysed by flow cytometry. There
were increased frequencies of CD41+ (88.3% versus 54.4%) and
CD45+ (45.2% versus 16.3%) cells and reduced frequencies of
TIE2+ (28.7% and 66.2%) cells following ENG induction (Fig. 4A).
TIE2+/CD117+ cells cultured in the presence or absence of Dox for
two days were also seeded into hematopoietic CFU assays. Again,
there was significant increase in the numbers of definitive
hematopoietic colonies following ENG induction (Fig. 4B). To
further evaluate whether ENG overexpression in TIE2+/CD117+
cells enriched numbers of functional hemogenic progenitors, we

Biology Open (2015) 4, 819-829 doi:10.1242/bio.011494

performed LDAs with sorted TIE2+/CD117+ cells with or without
Dox. At 48 hours, wells containing cells with hematopoietic
morphology were quantified. The number of blood producing
hemogenic progenitors had increased from 1:479 (untreated) to
1:225 (treated) (Fig. 4C). Taken together, these data show that
induction of ENG expression in FLK1+ cells or TIE2+/CD117+
promoted hematopoietic commitment and the emergence of CD45+
hematopoietic cells.
ENG induced acceleration of definitive hematopoiesis is
mediated by increased eNOS/NO activity

There is also an extensive body of evidence showing that ENG
increases eNOS expression by modulating Smad2 protein levels in
endothelial cells (Santibanez et al., 2007). Shear stress induced
expression of eNOS and NO production has been shown to enhance
hematopoiesis in ES/EB differentiation assays and also in vivo
(Adamo et al., 2009; North et al., 2009). Shear stress has also been
shown to increase ENG expression in endothelial cells, which in
turn mediates TGF-β/pSmad2 signaling and leads to the increase of
eNOS (Lebrin et al., 2004; Seghers et al., 2012). Therefore, we
speculated that the increase in definitive hematopoiesis that we
observed with ENG induction in FLK1+ and TIE2+/CD117+ cells
could be mediated by the ENG/pSmad2/eNOS/NO endothelial axis.
Indeed, cellular levels of pSMAD2 (Fig. 5Ai) and expression levels
of eNOS (Nos3) mRNA and protein (Fig. 5Aii,iii) were increased in
ENG induced cells. Furthermore, there was no change in protein
levels of SMAD2 (data not shown) and pSMAD1/5 (data not
shown). Induction of ENG in FLK1+ cells was accompanied by an
increase in intra-cellular NO levels, and this increase was blunted by

Fig. 4. Induction of high ENG expression in TIE2+/CD117+ cells results in the loss of endothelial markers and an increase in hematopoietic colony
formation. (A) A representative flow cytometry graph showing TIE2 and CD117 expression at day 2 of liquid blast culture of FLK1+ cells harvested from day 3 iEng
EBs. TIE2+/CD117+ cells were sorted and re-plated in liquid blast media for a further 48 hours in the presence or absence of Dox. The flow cytometry graphs to the
left show surface expression of CD41 and TIE2 in each fraction and the graphs to the right show surface expression of CD117 and CD45. (B) Bar chart showing the
number of hematopoietic colonies generated from cells collected from A. The error bars represent SEM values calculated from three independent biological
replicates performed in triplicate. (C) TIE2+/ CD117+ cells sorted from day 2 liquid blast cultures were seeded on to a 96 well plate in a limiting dilution assay (LDA)
to quantify the effect of ENG induction on the hematopoietic differentiation potential of TIE2+/CD117+ HE cells. The histograms represent the data obtained from
the LDA which shows that the frequency of blood emergence from HE cells increases from 1:479 (black) to 1:225 (red) upon induction of ENG. The P values were
generated from three independent biological replicates using a student t-test. *P<0.05.
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the addition of NG-nitro-L-arginine methyl ester (L-NAME), a
selective inhibitor of NOS enzymes (Fig. 5B). The addition of
L-NAME to liquid cultures of FLK1+ cells also restrained the
increase in ENG induced emergence of CD45+ cells and numbers of
definitive hematopoietic colonies (Fig. 5Ci,ii).
DISCUSSION

We have used an ES cell differentiation system to evaluate the
impact of ENG expression on hematopoietic commitment in
mesodermal progenitors. We report that FLK1+ mesodermal cells
that express ENG have reduced BL-CFC potential and are
committed towards a hematopoietic fate. FLK1+ cells from day 3
EBs subjected to high ENG expression showed increased capacity
to produce hemogenic endothelial, CD45+ hematopoietic cells and
definitive hematopoietic colonies. Forced ENG expression in
TIE2+/CD117+ cells from day 2 liquid cultures also showed
similar properties. ENG mediates the acceleration of hematopoiesis

from mesodermal and hemogenic progenitors by facilitating
increased eNOS and NO levels.
The TGF-β superfamily of ligands signal by binding a complex
of type 1 and type 2 receptors and mediating phosphorylation
of down-stream SMAD transcription factors to impact on gene
transcription. The identity of the type 1 receptors (ALK1 or ALK5)
that engage the ligand and its cognate type 2 receptor helps
determine whether downstream TGF-β signaling occurs via
the pSMAD1/5/8 pathway (ALK1) that promotes cell migration
and proliferation or the pSMAD2/3 pathway (ALK5), which is
associated with cell differentiation (Seghers et al., 2012). Shear
stress induced increase in ENG expression facilitates ALK5
mediated pSMAD2 phosphorylation and eNOS expression
(Santibanez et al., 2007; Seghers et al., 2012). Shear stress has
also been reported to increase hematopoietic colony-forming
potential and expression of hematopoietic markers in the paraaortic splanchnopleura/aorta-gonads-mesonephros of mouse
825
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Fig. 5. ENG induced acceleration of definitive hematopoiesis is mediated by increased eNOS/NO activity. (A) Western blots showing Smad2 (i) and eNOS
(ii) expression relative to β-actin in cells isolated at day 4 from liquid blast cultures of Dox treated and untreated iEng FLK1+ cells. (iii) RT-PCR showing Nos3
(eNOS) mRNA levels in FLK1+ cells after four days of treatment with or without Dox. (B) Bar chart showing the levels NO in cells harvested at day 3 from
liquid cultures of iEng:GFP FLK1+ cells with or without Dox treatment and in the presence or absence of L-NAME (2 mM final), an inhibitor of NOS enzymes.
(C) (i) Histogram showing ENG induced increase in CD45+/CD117+ hematopoietic cell emergence in liquid blast cultures and its modulation by L-NAME (ii) Bar
chart showing the number of hematopoietic colonies generated from cells harvested at day 4. The error bars represent SEM values calculated from three
independent biological replicates performed in triplicate. The P values were generated from three independent biological replicates and were calculated using
student t-tests. *P<0.05; **P<0.01.

embryos and that abrogation of nitric oxide, a mediator of shearstress-induced signalling, compromises hematopoietic potential
in vitro and in vivo (Adamo et al., 2009; North et al., 2009). Here we
show that stage specific overexpression of ENG was associated
with increased pSMAD2/eNOS and NO levels and abrogation of
eNOS activity blunted the increase in definitive hematopoiesis that
was mediated by high ENG. eNOS molecules have been reported to
bind the cytoplasmic region of the ENG receptor, where Hsp90
molecules reside. This ENG mediated proximity of eNOS and
Hsp90 generates a complex that catalyzes the degradation of
L-Arginine (L-Arg) to L-Citrulline (L-Cit) and generates NO
molecules. This eNOS/Hsp90 association is impaired in ENG−/−
ES cells, leading to decreased production of NO (Santibanez et al.,
2007; Toporsian et al., 2005).
The most direct evidence to show that the diminished BL-CFC
potential in a FLK1+ mesodermal cell that expressed ENG was
accompanied by commitment towards a haemogenic fate would
be to sort the same cell into both blast colony (BL-CFCs) and
liquid culture (haemogenic endothelial and blood) assays. As
this is beyond current limits of technology, we had to settle for
sorting FLK1+/ENG− or FLK1+/ENG+ cells from the same EB
differentiation assay into either BL-CFCs (Fig. 1B) or liquid
cultures (Fig. 2B). The data showed that FLK1+/ENG+ cells
produced fewer blast colonies but were more advanced in
expression of haematopoietic markers (CD41/45; Fig. 2B,D),
emergence of blood cells (Fig. 2C,E) than FLK1+/ENG− cells.
The decrease in BL-CFCs that we observed in ENG expressing
FLK1+ cells in day 3 EBs, contrasts with earlier reports that
ENG marked a population of cells with increased BL-CFC
activity (Perlingeiro, 2007). The number of BL-CFCs that can be
generated from ES/EB cultures is closely linked to the emergence
of FLK1+ cells. ES/EBs acquire FLK1 expression by day 2.5
(∼6% of cells), and this progressively increases to reach 20–30%
by day 4, after which it begins to fall (Fehling et al., 2003). The
number of blast colonies on the other hand peaks at day 3 and falls
sharply at day 4. There is therefore a window during ES/EB
differentiation, where FLK1+ cell numbers increase but BL-CFC
potential decreases. The numbers of BL-CFCs in the report
associating ENG expression with increased BL-CFC activity
(Perlingeiro, 2007) (10–30 BL-CFCs/5×104 FLK1+ cells from day
3 EBs) were considerably lower than those in this study (e.g.
2000–2500 BL-CFCs/2×104 FLK1+ cells from day 3 EBs;
Fig. 1Bii). The low numbers of BL-CFCs also coincided with
the presence of an unusually high number of FLK1+ cells at day 3
(∼75% versus ∼25%). Taken together, these data suggest that the
culture conditions might not have been ideal to assess functional
differences between cell fractions.
CD117 expression on day 3 FLK1+ cells has been reported as an
early marker of hematopoietic commitment (Kataoka et al., 1997).
It is noteworthy that CD117 expression in day 3 FLK1+ cells is
limited to a fraction of FLK1+/ENG+ cells and is not expressed on
FLK1+/ENG− cells (Fig. 2A). This again is consistent with
ENG as an early marker of hematopoietic commitment within a
pool of FLK1+ cells in day 3 EBs. ENG overexpression in bulk
populations of day 4–6 EBs has been reported to have no effect on
definitive hematopoietic colony formation (Baik et al., 2012). This
again contrasts with the observation that ENG overexpression in
relevant cell populations, i.e. FLK1+ cells from day 3 EBs that are
enriched in hemato-endothelial progenitors or in TIE2+/CD117+
cells in day 2 liquid cultures that are enriched in hemogenic
endothelial precursors, there is both an increase in definitive
hematopoietic colony formation and CD45+ cell emergence. Only
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a proportion of Tie2+/CD117+ intermediates in liquid cultures
possess functional HE potential (Lancrin et al., 2009). ENG
overexpression in TIE2+/CD117+ cells in day 2 liquid cultures led
to a decrease in CD117+ and 41+ expressing Tie2+ cells albeit
with increased functional HE cells. Whether this is due to
perturbation of surface marker expression or selection of cells that
progress in culture is not known. Bearing in mind that FLK1+
mesoderm is closer to the apex of embryonic haematopoiesis than
TIE2+/CD117+ cells, it is also interesting to note that forced
expression of ENG in the former have a greater impact (∼3 fold)
probably by increasing numbers of HE precursors than
perturbation in the latter (∼2 fold), which have a more restricted
differentiation potential. Taken together, this study underscores
the importance of using refined rather than bulk cell populations
when using ES/EB differentiation cultures to interpret the role of a
gene during early blood development.
Overall, our data supports a role for ENG in priming the
hemogenic program at a very early stage of embryonic
development i.e. as early as in FLK1+ mesodermal progenitors.
The observation that this is at least in part mediated by increased
NO synthesis is particularly relevant given the role of NO in
mediating shear induced HSC emergence from the aorta-gonadmesonephros during embryonic development (Adamo et al.,
2009; North et al., 2009). ENG expression in the AGM is
regulated by the ENG promoter in conjunction with an up-stream
−8 kb and two intronic +7 kb and +9 kb enhancers that
collectively assemble components of the Ets/Gata hemogenic
code (Pimanda et al., 2006; Pimanda et al., 2008). These cisregulatory elements of ENG are bound by FLI1, GATA2 and SCL
in E11.5 AGM which in turn constitute a recursively wired triad of
hematopoietic transcription factors that maintain each other’s
expression at this site by binding their own enhancer elements in
the AGM (Pimanda et al., 2007b). Constituents of the FLI1/
GATA2/SCL network that regulates ENG also regulates BMP
signaling and RUNX1 activity in the AGM (Narula et al., 2010;
Narula et al., 2013; Pimanda et al., 2007a). RUNX1 is required
for the in vivo generation of definitive hematopoietic cells (Okuda
et al., 1996) and its expression is also shear induced (Adamo et al.,
2009). Taken together with its role in potentiating NO synthesis
in endothelial cells, the transcriptional connectivity of ENG
expression in the AGM to a highly integrated regulatory network
that governs blood emergence (Marks-Bluth and Pimanda, 2012;
Pimanda and Göttgens, 2010), raises the prospect for a role for
ENG in promoting the emergence of definitive hematopoietic
cells from hemogenic precursors in the AGM.
MATERIALS AND METHODS
Murine ES cell culture and differentiation

The Bry/GFP (Fehling et al., 2003) and ENG −/− and ENG +/− (Cho et al.,
2001) murine ES cells have been previously described. Murine ES cells
were seeded on feeder coated plates in media composed of 84% Dulbecco’s
Modified Eagle Medium (DMEM, PAA Laboratories), 15% Fetal Bovine
serum (FBS, Invitrogen) pre-tested for maintenance of ES cells, 0.1% of
0.15 M dilution of monothioglycerol (MTG, Sigma Aldrich) and
1000 units/ml mouse recombinant Leukaemia inhibitory factor (Esgro,
Millipore). To generate EBs, cells were cultured in media consisting of
IMDM supplemented with 15% FBS (PAA laboratories) pretested for
efficient embryonic stem cell differentiation, 1% L-Glutamine (Invitrogen),
1% penicillin-streptomycin, 0.3% of 0.15 M MTG, 0.6% of 30 mg/ml
transferrin (Life Technologies) and 1% of 5 mg/ml ascorbic acid (Sigma
Aldrich). Cells were then seeded on ultra-low attachment 60 mm plates
(Sterilin) and placed in a humidified incubator at 37°C and 5% CO2. These
culture conditions were optimal for growth of day 1–5 EBs. Cells isolated
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from EB cultures were re-aggregated in EB media at a density of
5×104 cells/ml (Sroczynska et al., 2009).
Generating iEng ES cell line

Eng cDNA (Open Biosystems, clone MMM1013-202764815) was
amplified from the pCMV-SPORT6 plasmid using 5′-GAGAGATATCTCTCCGCCATGGACCGTGGC-3′ and 5′-GAGACTCGAGCGCCATGCTGCTGGTGGAGC-3′ (EcoRV and XhoI restriction sites respectively)
primers. The fragment was digested with EcoRV/XhoI restriction enzymes
and ligated into a 2A-eGFP-pLox backbone (Kyba et al., 2002). Plasmids
were sequenced using a BigDye Terminator Sequencing Kit (Life
Technologies). The expression plasmid was electroporated with Crerecombinase plasmid into Ainv18 ES cells (0.4 cm, Life Technologies) at
250 V and 450 μFaraday (201 Ω). Two days post electroporation the cells
were cultured in the presence of Neomycin (480 μg/ml final; Sigma
Aldrich), until the clones became visible. Primers used for sequencing were;
2A-eGFP F: ctgaaacagactttgaatttt, R: ttacttgtacagctcgtccatgcc; PA-SV40
R: tggtttgtccaaactcatcaa, pGKneo F: ctagatctcgaaggatctggag.
Liquid BL-CFC assay

Day 3 EBs were dissociated into single cells using trypsin (Gibco), and
stained with a Flk1-PE or Flk1-bio antibody (eBioscience). Sorted FLK1+
cells were seeded on gelatin coated plates at a density of 7.5–8.5×104
cells/9.6 cm2 (in a humidified incubator 37°C, 5% CO2). The culture
medium consisted of IMDM supplemented with 10% FBS pre-tested for
differentiation, 1% L-Glutamine, 0.6% 30 mg/ml transferrin, 0.3% 0.15 M
MTG, 0.5% 5 mg/ml ascorbic acid, 15% D4T conditioned medium, 0.1%
5 µg/ml VEGF, and 0.1% 10 µg/ml IL-6 (R&D systems).
Methylcellulose blast colony forming (BL-CFC) assay

2×104 FLK1+ cells collected from day 3.5–3 EBs were seeded in
methylcellulose mix which consisted of IMDM supplemented with 55%
methylcellulose (BioScientific), 10% FBS pretested for efficient EB
differentiation, 1% L-glutamine, 1% L-glutamine, 0.6% 30 mg/ml
transferrin, 0.3% 0.15 M MTG, 0.5% 5 mg/ml ascorbic acid, 15% D4T
conditioned media, 0.1% 5 µg/ml VEGF, and 0.1% 10 µg/ml IL-6. A 1 ml
syringe and 18 gauge blunt-end needle were used to aspirate the
methylcellulose mix onto 35 mm petri dishes. The blast potential in
Flk1+ cells was assayed in triplicate dishes of 1 ml. The plates were then
placed in a humidified incubator 37°C and 5% CO2. Colonies were scored
following four days of culture (Sroczynska et al., 2009).
Hematopoietic methylcellulose colony-forming assay

Cells isolated from day 2 or 4 of liquid blast cultures were seeded in media
containing IMDM supplemented with 55% methylcellulose, 15% plasma
derived serum (PDS, Animal Technologies), 10% protein-free hybridoma
medium (PFHMII, Invitrogen), 1% L-Glutamine, 0.6% 30 mg/ml
transferrin, 0.3% 0.15 M MTG, 0.5% 5 mg/ml ascorbic acid, 1% 10 µg/ml
kit ligand (KL), 0.1% 1 µg/ml IL-3, 0.3% 10 µg/ml G-CSF, 0.1% 5 µg/ml
IL-11, 0.2% erythropoietin at 2000 units/ml, 0.2% 5 µg/ml IL-6, 0.1%
5 µg/ml TPO, and 0.1% 10 µg/ml GM-CSF. Cells were seeded at a
concentration of 3×104 cells/ml, and the assay was set up in triplicate dishes
of 1 ml. Primitive colonies were scored after 4–5 days of culture, whereas
most definitive colonies were scored after 7–10 days. All cytokines used in
this assay were purchased from R&D systems (Sroczynska et al., 2009).
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Western blotting, 20–40 mg of protein per sample were loaded together
with LSD Sample Buffer (Invitrogen) and antioxidant (Invitrogen) onto a
10% polyacrylamide gel (Invitrogen) and electrophoresed for 20 minutes
at 80 V, followed by 60 minutes at 180 V in MOPS SDS Running buffer
(Novex). The SeeBluePlus2 (Invitrogen) marker was used as a molecular
weight indicator. Subsequently, proteins were transferred to nitrocellulose
membrane using the iBlot dry transfer system (Invitrogen). Transferred
proteins were visualized by reversibly staining membranes with Ponceau
S solution (Sigma) for 15 minutes. Membrane were washed with PBS
supplemented with 0.1% Tween20 (PBS/T), blocked in buffer containing
PBS/T and 5% fat-free powdered milk (Marvel) or 5% BSA and blotted
over-night with primary antibodies in blocking buffer. The eNOS (BD
Transduction Laboratories) was used at a 1:5000 dilution. The pSmad2
and pSmad1/5 (Cell Signaling Technology) were used at 1:1000 dilution.
The anti-rabbit-HRP and anti-mouse-HRP (Cell Signaling Technology)
were used at 1:10000 dilution. Following three washing steps, each for
5 minutes at room temperature in PBS/T, secondary antibodies were
applied. After a final set of washes, the membranes were developed with
ECL Plus Western Blotting detection reagents (Amersham), according to
manufacturer’s protocol and the membranes were transferred to an X-ray
film cassette. Films were exposed and developed in a MAS automated
developing machine. Antibodies were removed from the membrane by
15 minutes incubation in stripping buffer (200 mM glycine, 0.1% SDS,
1% Tween-20, pH 2.2). After three washing steps, the membranes were
blocked, as described previously, and primary antibody anti β-actin (Cell
Signaling Technology; 1:10000), was applied followed by the secondary
antibody.
The following antibodies were used; eNOS (BD Transduction
Laboratories; cat#610296; 1:5000), pSmad2 (Cell Signaling Technology;
cat#3101S; 1:1000), pSmad1/5 (Cell Signaling Technology; cat#9516S;
1:1000), Smad2/3 (Cell Signaling Technology; cat#3102S; 1:1000), β-actin
(Sigma; cat#A1978; 1:10000), anti-rabbit-HRP (Life Technologies;
cat#A24537; 1:10000) and anti-mouse-HRP (Cell signaling technology;
cat#7076; 1:10000).
RT-PCR

Prior to RNA isolation from samples, all equipment was treated with
RNaseZap (Ambion) to remove any contaminating RNases. RNA was
extracted using and RNeasy extraction kit (Qiagen) following
manufacturer’s instructions. Typically RNA was eluted with 30 μl RNasefree water. cDNA was then synthesised using the GoScript Reverse
Transcriptase (Promega) following manufacturer’s guidelines. Briefly, up to
5 μg of RNA was incubated with random primers and nuclease-free water at
70°C for 5 minutes, and then placed immediately on ice. A reverse
transcription mix (5× GoScript reaction buffer, MgCl2, 10 mM dNTP mix,
recombinant RNasin, GoScript reverse transcriptase and water) was added
to the denatured RNA for amplification. The cDNA was analysed for
expression using the Express SYBR Green QPCR Supermix Universal (Life
Technologies), following manufacturer’s guidelines.
The primers used for qPCR were; Eng F: aaatcccgttgcacttgg,
R: actcttggctgtccttggaa; Gata2 F: cacaagatgaatggacagaacc, R: acaggtgcccgctcttct; Fli1 F: ccccagccagatccttatc, R: cagctggatctgcccact; Nos3 F: atccagtgccctgcttca, R: gcagggcaagttaggatcag; B-actin F: tgacaggatgcagaagaaga,
R: cgctcaggaggagcaatg.

Cells were stained on ice for 30 minutes with either a biotinylated or
flurochrome-conjugated primary antibody. Dead cells were excluded
from the analysis on the basis of Hoechst 33258 uptake (1 µg/ml final
concentration; Invitrogen). A list of all primary and secondary antibodies
can be found in supplementary material Table S1. Flow cytometry analysis
was performed using standard flow cytometers; LSR or BD Canto II.
Sorting was performed on an Aria II, Influx or Jazz.
Western blot

Protein extractions were performed using RIPA lysis buffer. Protein
concentrations were quantified using Bradford assay (BioRad). For

NO levels were measured using the OxiSelect Intracellular Nitric
Oxide Assay Kit (Cell Biolabs, Inc.) according to the manufacturer’s
instructions. Briefly, on day 3 of liquid blast cultures, cells were
harvested and replated in the presence or absence of Dox and L-NAME
for 24 hours. Cells were then harvested and washed with PBS, followed
by incubation with 1× NO Fluorometric probe for 2 hours at 37°C and
5% CO2. 1× lysis buffer was added to the cultures and incubated for
5 minutes. 150 μl of the sample suspension was transferred to black
polystyrene half-area 96-well plates (Costar) and fluorescence was
measured at 485 nm/520 nm. The levels of NO were calculated
relative to fluorescence from the corresponding untreated cells (without
probe).
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Statistical analysis

For each experiment statistical analysis was performed by calculating the
standard error of the mean (SEM) across three independent experiments
each performed in triplicate for colony assays, and three independent
experiments for analyses of change in cell frequency over time between
different treatment conditions. Statistical significance of the results was
determined using unpaired t-tests. All P values were two-tailed and <0.05
and <0.001 were considered significant (*) and highly significant (**)
respectively.
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